National

Pricey COVID-19 test at border called 'irrational'

Darpan News Desk The Canadian Press, 04 Nov, 2021 10:04 AM

OTTAWA - The head of the Canadian Chamber of Commerce says it's "irrational" for Canada to require fully vaccinated travellers to complete an expensive COVID-19 test before crossing the border.

All travellers over the age of five, regardless of citizenship or vaccination status, must provide proof of a negative COVID-19 molecular test in order to enter the country.

It can cost between $150 and $300, making it prohibitively expensive for many families.

Perrin Beatty, president of the business group, says the test requirement does not appear to be based on science, and is redundant for fully vaccinated travellers.

The latest figures from the Public Health Agency of Canada show that of all COVID-19 tests completed at the border on vaccinated travellers between Aug. 9 and Oct. 21, only 0.18 per cent were positive.

For unvaccinated and partially vaccinated travellers, 0.91 per cent were positive.

Prev Next

MORE National ARTICLES

PM should promise to avoid pandemic election: MPs

The committee makes no similar call for opposition parties to promise not to trigger an election during the pandemic by voting non-confidence in the government.

PM should promise to avoid pandemic election: MPs

In-person gatherings important, says church lawyer

Chief Justice Christopher Hinkson said during a hearing on Tuesday people are still free to hold and express religious views and it's the safety of those who are gathering that's at issue.

In-person gatherings important, says church lawyer

One Arrested After Gasoline Poured On Tent, Occupants Threatened

The tent was occupied by a woman and her dog at the time of the incident. Patrol officers attended and located the suspect in Cecilia Ravine Park.

One Arrested After Gasoline Poured On Tent, Occupants Threatened

A look at the Oxford-AstraZeneca vaccine

On the one hand, Health Canada says Oxford-AstraZeneca’s vaccine has been deemed safe for seniors and points to emerging real-world data that shows it can protect older citizens against symptomatic infection.

A look at the Oxford-AstraZeneca vaccine

5.6M in funding for drug-dispensing machines

The machines, called MySafe, are similar to ATMs and allow drug users at risk of overdose to get hydromorphone pills dispensed to them after their palm has been scanned.

5.6M in funding for drug-dispensing machines

Ontario waits for guidance as B.C. delays 2nd dose

Alberto Martin, a University of Toronto immunology professor, says a published clinical trial showed the first dose of the Pfizer-BioNTech vaccine provided 60 per cent protection, but B.C. may have access to new or unpublished data.